[1] |
Mcdaniel B, Crane JS. Extramammary Paget disease[M]. Treasure Island (FL): StatPearls Publishing, 2019.
|
[2] |
van der Linden M, Meeuwis KA, Bulten J, et al. Paget disease of the vulva[J]. Crit Rev Oncol Hematol, 2016,101:60⁃74.doi: 10.1016/j.critrevonc.2016.03.008.
|
[3] |
Yang EJ, Kong CS, Longacre TA. Vulvar and anal intraepithelial neoplasia: terminology, diagnosis, and ancillary studies[J]. Adv Anat Pathol, 2017,24(3):136⁃150. doi: 10.1097/PAP.000000000 0000149.
|
[4] |
Hikita T, Ohtsuki Y, Maeda T, et al. Immunohistochemical and fluorescence in situ hybridization studies on noninvasive and invasive extramammary Paget′s disease[J]. Int J Surg Pathol, 2012,20(5):441⁃448. doi: 10.1177/1066896912444159.
|
[5] |
Diaz de Leon E, Carcangiu ML, Prieto VG, et al. Extramammary Paget disease is characterized by the consistent lack of estrogen and progesterone receptors but frequently expresses androgen receptor[J]. Am J Clin Pathol, 2000,113(4):572⁃575. doi: 10. 1309/P756⁃XXCB⁃TV71⁃U4XV.
|
[6] |
Press JZ, Allison KH, Garcia R, et al. FOXP3+ regulatory T⁃cells are abundant in vulvar Paget′s disease and are associated with recurrence[J]. Gynecol Oncol, 2011,120(2):296⁃299. doi: 10. 1016/j.ygyno.2010.10.019.
|
[7] |
Feng CC, Wang LJ, Zhou ZW, et al. Positive KI67 and periodic acid⁃schiff mandates wider range of excision in scrotal extramammary Paget′s disease[J]. Dermatol Surg, 2013,39(3 Pt 1):381⁃386. doi: 10.1111/dsu.12080.
|
[8] |
Smith RF, Stern BH, Smith AA. Mucin immunohistochemistry in the diagnosis and mapping of extramammary Paget′s disease[J]. J Cell Mol Med, 2008,12(5A):1605⁃1610. doi: 10.1111/j.1582⁃4934.2007.00188.x.
|
[9] |
Kang Z, Zhang Q, Zhang Q, et al. Clinical and pathological characteristics of extramammary Paget′s disease: report of 246 Chinese male patients[J]. Int J Clin Exp Pathol, 2015,8(10):13233⁃13240.
|
[10] |
Bontinck H, Bontinck J, Rondou T, et al. Perianal Paget′s disease: case report and review of the literature[J]. Acta Chir Belg, 2016,116(3):187⁃192. doi: 10.1080/00015458.2016.1139 832.
|
[11] |
Perrotto J, Abbott JJ, Ceilley RI, et al. The role of immunohistochemistry in discriminating primary from secondary extramammary Paget disease[J]. Am J Dermatopathol, 2010,32(2):137⁃143. doi: 10.1097/DAD.0b013e3181b71481.
|
[12] |
Kato J, Sumikawa Y, Hida T, et al. Serum cytokeratin 19 fragment 21⁃1 is a useful tumor marker for the assessment of extramammary Paget′s disease[J]. J Dermatol, 2017,44(6):666⁃670. doi: 10.1111/1346⁃8138.13760.
|
[13] |
Isik O, Aytac E, Brainard J, et al. Perianal Paget′s disease: three decades experience of a single institution[J]. Int J Colorectal Dis, 2016,31(1):29⁃34. doi: 10.1007/s00384⁃015⁃2342⁃3.
|
[14] |
Nomura H, Matoda M, Okamoto S, et al. Clinicopathologic features and treatment outcomes of primary extramammary Paget disease of the vulva[J]. J Low Genit Tract Dis, 2015,19(2):145⁃148. doi: 10.1097/LGT.0000000000000063.
|
[15] |
Peng X, Qian W, Hou J. 5⁃Aminolevulinic acid (5⁃ALA) fluorescence⁃guided Mohs surgery resection of penile⁃scrotal extramammary Paget′s disease[J]. Biosci Trends, 2017,11(5):595⁃599. doi: 10.5582/bst.2017.01224.
|
[16] |
Wang HW, Lv T, Zhang LL, et al. A prospective pilot study to evaluate combined topical photodynamic therapy and surgery for extramammary paget′s disease[J]. Lasers Surg Med, 2013,45(5):296⁃301. doi: 10.1002/lsm.22142.
|
[17] |
Gao Y, Zhang XC, Wang WS, et al. Efficacy and safety of topical ALA⁃PDT in the treatment of EMPD[J]. Photodiagnosis Photodyn Ther, 2015,12(1):92⁃97. doi: 10.1016/j.pdpdt.2014.11. 004.
|
[18] |
Jeon MS, Jung GY, Lee JH, et al. Extramammary Paget disease of the vulva: minimal excision with adjuvant radiation treatment for optimal aesthetic results[J]. Tumori, 2016,102(Suppl 2): S84⁃S86.doi: 10.5301/tj.5000394.
|
[19] |
Wan M, Ma H, Zhao Y, et al. Clinical benefits of preoperative conventional fluorescence diagnosis in surgical treatment of extramammary Paget disease[J]. Dermatol Surg, 2018,44(3):375⁃382. doi: 10.1097/DSS.0000000000001329.
|
[20] |
Perez DR, Trakarnsanga A, Shia J, et al. Management and outcome of perianal Paget′s disease: a 6⁃decade institutional experience[J]. Dis Colon Rectum, 2014,57(6):747⁃751. doi: 10. 1097/DCR.0000000000000100.
|
[21] |
Fanning J, Lambert HC, Hale TM, et al. Paget′s disease of the vulva: prevalence of associated vulvar adenocarcinoma, invasive Paget′s disease, and recurrence after surgical excision[J]. Am J Obstet Gynecol, 1999,180(1 Pt 1):24⁃27. doi: 10.1016/s0002⁃9378(99)70143⁃2.
|
[22] |
Ciavattini A, Sopracordevole F, Di Giuseppe J. Surgical treatment of Paget disease of the vulva: prognostic significance of stromal invasion and surgical margin status[J]. J Low Genit Tract Dis,2016,20(3):e53⁃e54. doi: 10.1097/LGT.0000000000000232.
|
[23] |
Jung JH, Kwak C, Kim HH, et al. Extramammary Paget disease of external genitalia: surgical excision and follow⁃up experiences with 19 patients[J]. Korean J Urol, 2013,54(12):834⁃839. doi: 10.4111/kju.2013.54.12.834.
|
[24] |
Lam DT, Batista O, Weiss EG, et al. Staged excision and split⁃thickness skin graft for circumferential perianal Paget′s disease[J]. Dis Colon Rectum, 2001,44(6):868⁃870. doi: 10.1007/bf02 234711.
|
[25] |
Shen K, Luo H, Hu J, et al. Perianal Paget disease treated with wide excision and thigh skin flap reconstruction: a case report and review of literature[J]. Medicine (Baltimore), 2018,97(30):e11638. doi: 10.1097/MD.0000000000011638.
|
[26] |
Bae JM, Choi YY, Kim H, et al. Mohs micrographic surgery for extramammary Paget disease: a pooled analysis of individual patient data[J]. J Am Acad Dermatol, 2013,68(4):632⁃637. doi: 10.1016/j.jaad.2012.12.960.
|
[27] |
Hendi A, Brodland DG, Zitelli JA. Extramammary Paget′s disease: surgical treatment with Mohs micrographic surgery[J]. J Am Acad Dermatol, 2004,51(5):767⁃773. doi: 10.1016/j.jaad. 2004.07.004.
|
[28] |
Lee KY, Roh MR, Chung WG, et al. Comparison of Mohs micrographic surgery and wide excision for extramammary Paget′s Disease: Korean experience[J]. Dermatol Surg, 2009,35(1):34⁃40. doi: 10.1111/j.1524⁃4725.2008.34380.x.
|
[29] |
Long B, Schmitt AR, Weaver AL, et al. A matter of margins: surgical and pathologic risk factors for recurrence in extramammary Paget′s disease[J]. Gynecol Oncol, 2017,147(2):358⁃363. doi: 10.1016/j.ygyno.2017.09.008.
|
[30] |
Kim SJ, Thompson AK, Zubair AS, et al. Surgical treatment and outcomes of patients with extramammary Paget disease: a cohort study[J]. Dermatol Surg, 2017,43(5):708⁃714. doi: 10.1097/ DSS.0000000000001051.
|
[31] |
Damavandy AA, Terushkin V, Zitelli JA, et al. Intraoperative immunostaining for cytokeratin⁃7 during Mohs micrographic surgery demonstrates low local recurrence rates in extramammary Paget′s disease[J]. Dermatol Surg, 2018,44(3):354⁃364. doi: 10.1097/DSS.0000000000001355.
|